Report Highlights
The global market for cardiac medical devices was valued at nearly $49.4 billion in 2013 and $52 billion in 2014. This market is projected to reach nearly $67.5 billion by 2019, with a compound annual growth rate (CAGR) of 5.3% from 2014 to 2019.
Report Includes
- An overview of the technologies and global markets for cardiac equipment.
- Analyses of global market trends, with data from 2012 to 2014, and projections of CAGRs through 2019.
- Breakdowns of the market based on market share, product types, and geography.
- Information on cardiac equipment currently used in the market, as well as what will likely be commercialized in the near future.
- Information pertaining to the suppliers of the equipment.
- Analysis of the market's dynamics, specifically growth drivers, inhibitors, and opportunities.
- Profiles of major players in the cardiac equipment field.
SCOPE OF REPORT
The scope of this study encompasses multiple technologies and procedures related to cardiac devices. The study focuses primarily on four main categories of cardiac devices:
- Diagnostic devices.
- Implantable devices.
- Defibrillators.
- Heart pumps and heart-lung machines.
The diagnostic devices include monitoring devices such as echocardiography (ECG or EKG), ultrasound, Doppler, pulse oximetry, end-tidal carbon dioxide (ETCO2), capnography, noninvasive blood pressure (NIBP), and stress tests. The implantable devices include implantable cardioverter defibrillators (ICDs), pacemakers, cardiac monitors, stents, percutaneous transluminal angioplasty (PTA) and insertable cardiac monitors (ICMs). The defibrillators include advanced life support defibrillators (ALSs), automated external defibrillators (AEDs) and wearable defibrillators. The heart pumps segment includes balloon pumps, cardiopulmonary bypass pumps, ventricular assist devices (VADs) and left ventricular assist systems (LVAS). Heart-lung machines are also important products in the cardiac device market. BCC Research analyzes each market and its applications, regulatory environment, technology, market projections and market shares for the major players. The report also analyzes the market by region, which consists of North America, Europe and emerging markets, including countries like India, China, Japan, Korea, Taiwan, Canada, Africa, Australia, New Zealand, etc.
Analyst Credentials
Shalini Shahani Dewan focuses on pharmaceuticals and biotechnology and has been a BCC Research contributor since 2002 as both an analyst and project manager. She has explored a wide range of topics and companies, including working for Johnson & Johnson doing market surveillance. She has an undergraduate degree in pharmacy and master's degree in medicinal chemistry. She resides in the Bay Area.
Related Reports
Ambulance and Emergency Equipment: Global Markets
The global market for ambulance and emergency medical services (EMS) equipment in 2012 was $5.8 billion and reached $5.9 billion in 2013. At a 2.9% compound annual growth rate (CAGR) from 2013 to 2018, this market is expected to rise to $6.8 billion in 2018.
Ultrasonics: Technologies and Global Markets
The global ultrasonic market reached nearly $21.5 billion in 2013. This market is expected to grow to nearly $26.6 billion in 2015 and $45.2 billion in 2020 with a compound annual growth rate (CAGR) of 11.2% over the five-year period from 2015 to 2020.
JAK and PI3K Signaling Pathway Markets
The global market for signal transduction therapies/inhibitors (JAK and PI3K) reached $173.5 million in 2012. This market is expected to grow to $464.5 million in 2013 and $2.2 billion in 2018 with a compound annual growth rate (CAGR) of 36.8% over the five-year period from 2013 to 2018.
Cardiac Biomarkers: Technologies and Global Markets
The global market for in vitro diagnostic tests for cardiac biomarkers was estimated at $3.1 billion in 2012 and nearly $4 billion in 2013. This market is predicted to reach $7.2 billion by 2018, at a compound annual growth rate (CAGR) of 12.8% over the five-year period from 2013 to 2018.
Recent Reports
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Top Trending Reports
AI in Clinical and Molecular Diagnostics Market
The global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period of 2024 to 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Artificial Intelligence (AI) Market: Investments vs Potential
The global market for artificial intelligence (AI) is estimated to increase from $148.8 billion in 2023 to reach $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 39.7% from 2024 through 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More